Amneal (NYSE: AMRX) EVP Boyer settles RSUs, withholds stock for tax
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Amneal Pharmaceuticals, Inc. Executive Vice President Andrew S. Boyer reported multiple equity award vestings and related share transfers. On March 3, 2026, performance-based restricted stock units, including 397,554 performance-based RSUs, were certified as having met their performance threshold and vested, then settled into an equal number of Class A Common Stock shares on a one-for-one basis. Several time-based restricted stock unit grants also vested and were settled into Class A Common Stock.
To cover tax withholding obligations tied to these vestings, Boyer had blocks of Class A Common Stock withheld, including 199,175 shares at $13.31 per share and 19,136 shares at $13.30 per share, classified as tax-withholding dispositions. Following the transactions on March 4, 2026, Boyer directly held 426,072 shares of Amneal Class A Common Stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
548,953 shares exercised/converted
Mixed
15 txns
Insider
BOYER ANDREW S
Role
Executive Vice President
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 38,195 | $0.00 | -- |
| Exercise | Class A Common Stock | 38,195 | $0.00 | -- |
| Tax Withholding | Class A Common Stock | 19,136 | $13.30 | $255K |
| Exercise | Restricted Stock Units | 39,252 | $0.00 | -- |
| Exercise | Restricted Stock Units | 49,694 | $0.00 | -- |
| Exercise | Restricted Stock Units | 24,258 | $0.00 | -- |
| Exercise | Performance-Based Restricted Stock Units | 397,554 | $0.00 | -- |
| Exercise | Class A Common Stock | 39,252 | $0.00 | -- |
| Tax Withholding | Class A Common Stock | 19,945 | $13.31 | $265K |
| Exercise | Class A Common Stock | 49,694 | $0.00 | -- |
| Tax Withholding | Class A Common Stock | 24,897 | $13.31 | $331K |
| Exercise | Class A Common Stock | 24,258 | $0.00 | -- |
| Tax Withholding | Class A Common Stock | 12,154 | $13.31 | $162K |
| Exercise | Class A Common Stock | 397,554 | $0.00 | -- |
| Tax Withholding | Class A Common Stock | 199,175 | $13.31 | $2.65M |
Holdings After Transaction:
Restricted Stock Units — 76,389 shares (Direct);
Class A Common Stock — 445,208 shares (Direct);
Performance-Based Restricted Stock Units — 0 shares (Direct)
Footnotes (1)
- Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units. Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. On March 3, 2023, the Reporting Person was granted performance-based restricted stock units, scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period. These units were certified as meeting the performance threshold that resulted in vesting of 200% of the targeted number of restricted stock units and these restricted stock units were deemed earned and vested on March 3, 2026 and settled into shares of Class A Common Stock on a one-for-one basis. Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of these performance-based restricted stock unites. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 5. Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of performance-based restricted stock units. On March 4, 2022, the reporting person was granted 157,005 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date. On March 3, 2023, the reporting person was granted 198,777 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date. On March 3, 2025, the reporting person was granted 97,032 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date. On March 4, 2024, the reporting person was granted 152,778 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.
FAQ
What did Amneal (AMRX) executive Andrew S. Boyer report in this Form 4 filing?
Andrew S. Boyer reported vesting and settlement of restricted stock units and performance-based restricted stock units into Amneal Class A Common Stock, along with share withholdings used to satisfy tax obligations related to those equity awards.
How many performance-based restricted stock units vested for AMRX executive Andrew Boyer?
Andrew Boyer had 397,554 performance-based restricted stock units certified as meeting their performance threshold. These units vested and were settled into an equal number of Amneal Class A Common Stock shares on a one-for-one basis after the three-year performance period.
What triggered the vesting of Andrew Boyer’s performance-based RSUs at Amneal (AMRX)?
The performance-based restricted stock units vested after Amneal’s Class A Common Stock achieved specified average closing prices over a three-year performance period. This certification resulted in 200% of the target number of units vesting and settling into common shares.